After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, AKRO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Akero Therapeutics Inc is $3.57B. A total of 0.87 million shares were traded on the day, compared to an average of 1.31M shares.
In the most recent transaction, Cheng Andrew sold 1,738 shares of AKRO for 44.88 per share on Mar 12 ’25. After the transaction, the President and CEO now owns 654,324 company shares. In a previous transaction on Mar 12 ’25, Young Jonathan sold 607 shares at 44.88 per share. AKRO shares that Chief Operating Officer owns now total 200,540.
Among the insiders who sold shares, Yale Catriona disposed of 614 shares on Mar 12 ’25 at a per-share price of $44.88. This resulted in the Chief Development Officer holding 95,034 shares of AKRO after the transaction. In another insider transaction, White William Richard sold 676 shares at $44.88 per share on Mar 12 ’25. Company shares held by the Chief Financial Officer now total 61,959.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, AKRO has a high of $58.40 and a low of $17.86.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AKRO’s latest balance sheet shows that the firm has $188.26M in Cash & Short Term Investments as of fiscal 2021. There were $1.52M in debt and $25.13M in liabilities at the time. Its Book Value Per Share was $10.36, while its Total Shareholder’s Equity was $169.11M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AKRO is Buy with a score of 5.00.
